Why is P & G Health Ltd falling/rising?

As of 29-Aug, Procter & Gamble Health Ltd's stock price is rising, currently at Rs. 6,311.70, reflecting an increase of 27.1 points or 0.43%. The stock has recently hit a new 52-week high of Rs. 6,700 and has shown a positive performance today, outperforming its sector by 0.4%. It has gained consecutively over the last two days, with a total return of 0.5% in this period. Despite a slight decline of 3.99% over the past week, the stock has performed well over the last month with a 6.63% increase, and it has generated impressive returns of 20.80% over the past year, significantly outperforming the broader market. The company’s strong fundamentals, including high management efficiency with a return on equity (ROE) of 32.32% and consistent positive quarterly results, contribute positively to its stock performance.
In the broader market context, while the Sensex has declined by 1.84% over the past week, Procter & Gamble Health Ltd's short-term performance has been notably better, indicating resilience against market trends. The stock's long-term performance has also been strong, outperforming the BSE500 over various periods, including a 51.31% increase over the last three years. However, there are concerns regarding its long-term growth potential, as net sales have only grown at an annual rate of 7.39% over the last five years, and the stock is considered expensive with a price-to-book value of 19.5. Despite these risks, the high institutional holdings at 21.15% suggest confidence from more knowledgeable investors, which may help sustain the stock's upward momentum.